1.
Liu J, Cao S, Imbach KJ, et al. Multi-scale signaling and tumor evolution in high-grade gliomas. Cancer cell. 2024;42(7):1217-1238.e19. doi:10.1016/j.ccell.2024.06.004.
1.
Li GX, Chen L, Hsiao Y, et al. Comprehensive proteogenomic characterization of rare kidney tumors. Cell reports. Medicine. 2024:101547. doi:10.1016/j.xcrm.2024.101547.
1.
Li Y, Lih T-SM, Dhanasekaran SM, et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer cell. 2023;41(1):139-163.e17. doi:10.1016/j.ccell.2022.12.001.
1.
Wang JM, Hong R, Demicco EG, et al. Deep learning integrates histopathology and proteogenomics at a pan-cancer level. Cell reports. Medicine. 2023:101173. doi:10.1016/j.xcrm.2023.101173.
1.
Geffen Y, Anand S, Akiyama Y, et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell. 2023. doi:10.1016/j.cell.2023.07.013.
1.
Li Y, Porta-Pardo E, Tokheim C, et al. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell. 2023. doi:10.1016/j.cell.2023.07.014.
1.
Li Y, Dou Y, Leprevost F da V, et al. Proteogenomic data and resources for pan-cancer analysis. Cancer cell. 2023;41(8):1397-1406. doi:10.1016/j.ccell.2023.06.009.
1.
Dou Y, Katsnelson L, Gritsenko MA, et al. Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer cell. 2023. doi:10.1016/j.ccell.2023.07.007.